Bifidobacterium animalis subsp lactis HN019
Selected indexed studies
- Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review. (Front Nutr, 2021) [PMID:34970580]
- Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. (Gut Microbes, 2018) [PMID:29227175]
- Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial. (Gut Microbes, 2023) [PMID:37078654]
_Worker-drafted node — pending editorial review._
Connections
Bifidobacterium animalis subsp lactis HN019 helps
Sources
- Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial. (2023) pubmed
- Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review. (2021) pubmed
- Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. (2018) pubmed
- Eight-Week Supplementation With Bifidobacterium lactis HN019 and Functional Constipation: A Randomized Clinical Trial. (2024) pubmed
- Use of the Probiotic Bifidobacterium animalis subsp. lactis HN019 in Oral Diseases. (2022) pubmed
- Impact of Bifidobacterium animalis subsp. lactis HN019 probiotic in the prevention of periodontitis associated with immunosuppression. (2023) pubmed
- Bifidobacterium animalis subsp. lactis HN019 has antimicrobial activity against endodontic pathogens in vitro. (2023) pubmed
- Bifidobacterium animalis subsp. lactis HN019 live probiotics and postbiotics: production strategies and bioactivity evaluation for potential therapeutic properties. (2024) pubmed
- Benefits of Bifidobacterium animalis subsp. lactis Probiotic in Experimental Periodontitis. (2017) pubmed
- Bifidobacterium animalis subsp lactis HN019 presents antimicrobial potential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients. (2020) pubmed